US Patent Issued to Arizona Board of Regents on Behalf of the University of Arizona on Jan. 20 for "Small molecule inhibitors of DYRK/CLK and uses thereof" (Arizona Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,810, issued on Jan. 20, was assigned to Arizona Board of Regents on Behalf of the University of Arizona (Tucson, Ariz.).

"Small molecule inhibitors of DYRK/CLK and uses thereof" was invented by Christopher Hulme (Tucson, Ariz.) and Christopher Foley (Tucson, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a 6,5-heterocyclic structure (e.g., compounds having a imidazopyridine, imidazopyrimidine, imidazopyrazine, imidazopyridazine, imidazotriazine, benzoimidazole, benzotriazole, benzoisoxazole, purine, indazole, tri...